Background. Radiolabeled antibody specific for cardiac myosin administ
ered intravenously has been used to define noninvasively regions of my
ocardial necrosis. Inflammatory heart disorders such as myocarditis an
d heart transplant rejection demonstrate diffuse and often faint myoca
rdial uptake of antimyosin antibody. This study was undertaken to eval
uate the reproducibility and diagnostic accuracy of antimyosin antibod
y imaging for the detection of patients with suspected myocarditis. Me
thods and Results. Fifty antimyosin scans, performed consecutively in
patients with suspected myocarditis, were evaluated by one independent
observer and two panels of observers. Antimyosin scan interpretations
were compared with endomyocardial biopsy results and also with serial
changes in left ventricular function. An independent observer (A) and
a panel of five observers (A through E) interpreted the antimyosin sc
ans as positive or negative on the basis of both planar images and tom
ographic reconstructions. Three of the five observers (A through C) ag
ain interpreted the scans but based interpretation only on planar imag
es. Blinded random sequence evaluation of antimyosin scans based on th
e planar and tomographic interpretations revealed moderate agreement b
etween the independent observer (A) and the group of observers (A thro
ugh E) (kappa = 0.58). There was also moderate agreement between inter
pretations based on planar images alone and interpretations based on b
oth planar and tomographic images (kappa [A through E]/[A through C] =
0.57; kappa [A through C]/A = 0.48). Comparison of antimyosin scan re
sults with histologic evidence of myocarditis in endomyocardial biopsy
specimens demonstrated that all scan results obtained from the indivi
dual or the panels of observers had a very high sensitivity (91% to 10
0%) and a high negative predictive value (93% to 100%). The specificit
y (31% to 44%) and positive predictive value (28% to 33%) were less im
pressive. We also compared the scan and biopsy results with the compos
ite clinical standard of significant left ventricular functional impro
vement. Endomyocardial biopsy demonstrated poor sensitivity (35%) comp
ared with antimyosin scans (82% to 94%) but had superior specificity (
endomyocardial biopsy, 79%; antimyosin scan, 25% to 42%). The specific
ity of interpretations based on planar and tomographic interpretations
(38% to 42%) was better than the planar images alone (25%). If revers
ible left ventricular dysfunction is considered clinical evidence of m
yocarditis, this study suggests that a negative endomyocardial biopsy
significantly misses the presence of the disease. On the other hand, a
negative antimyosin scan almost invariably excludes myocarditis. Conc
lusions. This study demonstrates a high degree of interobserver reprod
ucibility of antimyosin interpretation. Comparison of the scintigraphi
c results with histologic and clinical standards indicates a high sens
itivity of antimyosin scans for the detection of myocarditis. The anti
myosin scan is also not likely to miss clinically or pathologically di
agnosed myocarditis, in contrast to the endomyocardial biopsy, which m
issed clinically validated myocarditis 65% of time. The combination of
high sensitivity and negative predictive value suggests that antimyos
in scintigraphy may be an effective screening procedure for obviating
biopsies in patients with suspected myocarditis.